NASDAQ

Coherus Oncology, Inc. (CHRS)

♥ 564 Thanks from members

Live price chart, market sentiment, and community perspectives for Coherus Oncology, Inc. (NASDAQ: CHRS).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Denny LanfearLeadership: Denny Lanfear (CEO)Leadership: McDavid StilwellHolder: BlackRock Inc.Holder: Vanguard GroupHolder: Baker Bros. AdvisorsUDENYCACIMZIA biosimilar candidateCHR-2583Oncology biologics#CHRS stock#Coherus Oncology#Biosimilars biotech#Oncology treatments#NASDAQ CHRS